Skip to content

13F-HR filed by GREAT POINT PARTNERS LLC

GREAT POINT PARTNERS LLC filed this 13F-HR for the quarter ended 2015-03-31, filed 2015-05-15, with 33 holding rows worth $227,217,000.

Accession
0000930413-15-002517
Filed
2015-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2015

A holdings report, 35 entries on the cover page, a total value of $227,217,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $227,217,000 with VALUE read as thousands by filing date, 13F file number 028-11743. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CONNECTURE INC COM20786J106Stock5,502,965$56,956,000thousands by filing date
HYPERION THERAPEUTICS INC44915N101COM500,000$22,950,000thousands by filing date
VANDA PHARMACEUTICALS INC921659108COM1,388,599$12,914,000thousands by filing date
ORTHOFIX INTL N VN6748L102COM300,000$10,767,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM608,650$10,645,000thousands by filing date
OCERA THERAPEUTICS INC COM67552A108COM1,963,777$9,249,000thousands by filing date
ALIMERA SCIENCES INC016259103COM1,731,550$8,675,000thousands by filing date
AURINIA PHARMACEUTICALS INC COM05156V102Stock1,941,144$8,511,000thousands by filing date
DERMA SCIENCES INC249827502COM PAR $.01977,923$8,283,000thousands by filing date
VERICEL CORP92346J108COM2,086,028$7,718,000thousands by filing date
VERSARTIS INC92529L102COM385,000$7,072,000thousands by filing date
SUCAMPO PHARMACEUTICALS-CL A864909106CL A450,000$7,002,000thousands by filing date
STEMLINE THERAPEUTICS INC85858C107COM475,200$6,877,000thousands by filing date
ARADIGM CORP038505400COM NO PAR NEW1,002,962$6,338,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR339,863$5,896,000thousands by filing date
Alcobra LtdM2239P109SHS983,786$5,539,000thousands by filing date
DYAX CORP26746E103COM235,950$3,953,000thousands by filing date
HERON THERAPEUTICS INC427746102COM270,000$3,929,000thousands by filing date
TENAX THERAPEUTICS INC88032L100COM1,108,593$3,614,000thousands by filing date
Ampio Pharmaceuticals03209T109COM421,500$3,174,000thousands by filing dateput
ENANTA PHARMACEUTICALS INC29251M106COM100,000$3,062,000thousands by filing date
EMERGENT BIOSOLUTIONS INC29089Q105COM102,791$2,956,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW1,038,652$2,545,000thousands by filing date
ATHERSYS INC04744L106COM830,200$2,391,000thousands by filing datecall
MELA SCIENCES INC55277R308COM NEW569,591$1,464,000thousands by filing date
BELLICUM PHARMACEUTICALS INC079481107COM50,000$1,159,000thousands by filing date
BOVIE MEDICAL CORP10211F100COM480,000$1,147,000thousands by filing date
VICAL INC925602104COM846,762$800,000thousands by filing date
STREAMLINE HEALTH SOLUTIONS86323X106COM151,611$538,000thousands by filing date
VERACYTE INC COM92337F107Stock68,158$497,000thousands by filing date
ATHERSYS INC04744L106COM100,000$288,000thousands by filing dateput
OSIRIS THERAPEUTICS INC NEW68827R108COM12,165$214,000thousands by filing date
MEI PHARMA INC55279B202COM NEW52,254$94,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000930413-15-002517this filing2015-05-15acceptance time not in the bulk data set